机构

• 合肥物质科学研究院 [7]
• 海洋研究所 [2]
• 计算技术研究所 [1]
• 宁波材料技术与工程研... [1]
• 化学研究所 [1]
• 上海天文台 [1]
• 更多

采集方式

• OAI收割 [17]

内容类型

• 期刊论文 [17]

发表日期

• 2023 [1]
• 2021 [2]
• 2020 [1]
• 2019 [3]
• 2018 [2]
• 2017 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共17条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Deep Learning-based Moving Object Segmentation: Recent Progress and Research Prospects 期刊论文  OAI收割 Machine Intelligence Research, 2023, 卷号: 20, 期号: 3, 页码: 335-369 作者:  Rui Jiang;  Ruixiang Zhu;  Hu Su;  Yinlin Li;  Yuan Xie   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/04/23 Moving object segmentation (MOS), change detection, background subtraction, deep learning (DL), video understanding   Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897 作者:  Lu, Tingting;  Cao, Jiangyan;  Zou, Fengming;  Li, Xixiang;  Wang, Aoli   |  收藏  |  浏览/下载：57/0  |  提交时间：2021/04/26 BCR-ABL  ABL mutants  Chronic myeloid leukemia  Kinase inhibitor  Imatinib resistance   Selectively targeting FLT3-ITD mutants over FLT3-wt by a novel inhibitor for acute myeloid leukemia 期刊论文  OAI收割 HAEMATOLOGICA, 2021, 卷号: 106 作者:  Wang, Aoli;  Hu, Chen;  Chen, Cheng;  Liang, Xiaofei;  Wang, Beilei   |  收藏  |  浏览/下载：69/0  |  提交时间：2021/04/26 Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia 期刊论文  OAI收割 EXPERIMENTAL CELL RESEARCH, 2020, 卷号: 393 作者:  Chen, Cheng;  Wang, Li;  Li, Lili;  Wang, Aoli;  Huang, Tao   |  收藏  |  浏览/下载：55/0  |  提交时间：2020/11/26 Acute myeloid leukemia (AML)  Drug response  Gene mutations   Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文  OAI收割 CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885 作者:  Wu, Jiaxin;  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Qi, Ziping   |  收藏  |  浏览/下载：88/0  |  提交时间：2019/11/27 BCR-ABL  PDGFR  chronic myeloid leukemia  kinase inhibitor   Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 2, 页码: 875-892 作者:  Liang, Xiaofei;  Wang, Beilei;  Chen, Cheng;  Wang, Aoli;  Hu, Chen   |  收藏  |  浏览/下载：40/0  |  提交时间：2020/05/21 Simultaneous Bottom-Up Interfacial and Bulk Defect Passivation in Highly Efficient Planar Perovskite Solar Cells using Nonconjugated Small-Molecule Electrolytes 期刊论文  OAI收割 ADVANCED MATERIALS, 2019, 卷号: 31, 期号: 40 作者:  Zheng, Ding;  Peng, Ruixiang;  Wang, Gang;  Logsdon, Jenna Leigh;  Wang, Binghao   |  收藏  |  浏览/下载：36/0  |  提交时间：2019/12/18 CATHODE MODIFICATION  ENHANCEMENT  MORPHOLOGY  BEHAVIOR  LAYERS  PHASE  FILMS   Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 160, 页码: 61-81 作者:  Liu, Xuesong;  Wang, Beilei;  Chen, Cheng;  Jiang, Zongru;  Hu, Chen   |  收藏  |  浏览/下载：51/0  |  提交时间：2019/01/11 ABL kinase  Kinase inhibitor  ABL mutant  CML   Comprehensive Characterization of Swine Cardiac Troponin T Proteoforms by Top-Down Mass Spectrometry 期刊论文  OAI收割 JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2018, 卷号: 29, 期号: 6, 页码: 1284-1294 作者:  Lin, Ziqing;  Guo, Fang;  Gregorich, Zachery R.;  Sun, Ruixiang;  Zhang, Han   |  收藏  |  浏览/下载：40/0  |  提交时间：2019/12/10 Cardiac troponin  Heart disease  Proteoform  Top-down proteomics  Collisionally activated dissociation  Electron-transfer dissociation  Electron-capture dissociation   Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 20, 页码: 8407-8424 作者:  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Wu, Hong;  Qi, Ziping   |  收藏  |  浏览/下载：54/0  |  提交时间：2019/06/17